CVTTHi001-A-1
General
Cell Line |
|
hPSCreg name | CVTTHi001-A-1 |
Cite as: | CVTTHi001-A-1 |
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 24th September 2024 |
User feedback | |
Provider |
|
Generator | Centro Vasco de Transfusión y Tejidos Humanos (CVTTH) |
External Databases |
|
BioSamples | SAMEA115903643 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Subclone of |
Donor Information
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA7274737 |
Ethics
Also have a look at the ethics information for the parental line
CVTTHi001-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
CVTTHi001-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Medium |
Essential 8™
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|||||
SSEA-4 |
Yes |
Morphology pictures
Differentiation Potency
In vitro directed differentiation
Morphology
In vitro directed differentiation
Morphology
In vitro directed differentiation
Morphology
Genotyping
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.